Evidence map›Paper›PMID 40150787›Full record

ArticleBioengineering (Basel, Switzerland)2025

Robustness of the

Lucas Becker, Emely Dietz, Dirk Holtmann

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lucas BeckerBioprocess Intensification, Institute of Bioprocess Engineering and Pharmaceutical Technology, Technische Hochschule Mittelhessen, 35390 Giessen, Germany.
Emely DietzBioprocess Intensification, Institute of Bioprocess Engineering and Pharmaceutical Technology, Technische Hochschule Mittelhessen, 35390 Giessen, Germany.
Dirk HoltmannInstitute of Process Engineering in Life Sciences, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany.ORCID 0000-0001-5540-3550

Funding

Federal Ministry of Education and Research (BMBF) 01B1050A
6 · The paper itself

Abstract

The increasing global demand for natural substances such as the sesquiterpene α-humulene makes optimizing microbial production essential. A production process using the versatile host

Indexed as

Cupriavidus necatorpreculture variationprocess robustnessterpenesα-humulene

Identifiers

PMID40150787
PMCPMC11939629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.